SCHEMBL6487283

SCHEMBL6487283

CCOC(=O)c1c(C)cccc1COc1cc(C)c2nc(C)n(Cc3ccc(-c4ncco4)cc3Cl)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3C2B O00750 4/20 0.35
ALDH1A1 P00352 4/20 0.34
MAPT P10636 3/20 0.34
GAA P10253 2/20 0.34
LMNA P02545 2/20 0.34
KDM4E B2RXH2 2/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
USP7 Q93009 2/20 0.33
USP2 O75604 1/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CMA1 P23946 1/20 0.32
PIK3CB P42338 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489403 0.92 PIK3C2B (0.40) PIK3C2BUSP7PIK3CB
SCHEMBL6488725 0.90 ALOX5AP (0.37) ALDH1A1MAPTGAALMNAMAPK1
SCHEMBL6488053 0.87 BCL2 (0.43) PIK3C2BPIK3CB
SCHEMBL6488587 0.86 BCL2 (0.37) PIK3C2BMAPTSMN1; SMN2DCTPP1P2RX7
SCHEMBL6490138 0.84 LTA4H (0.36) ALDH1A1MAPTGAAKDM4EUSP7
SCHEMBL6501700 0.82 MCL1 (0.40) ALDH1A1MAPTGAALMNAL3MBTL1
SCHEMBL6500310 0.81 ALOX5AP (0.40) MAPT
SCHEMBL6496471 0.81 DCTPP1 (0.37) PIK3C2BALDH1A1MAPTGAATDP1
SCHEMBL6491035 0.81 LTA4H (0.41) PIK3C2BUSP7
SCHEMBL6498329 0.80 MAPT (0.41) ALDH1A1MAPTKDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD PIK3C2B 2433/4885ALDH1A1 96/4885MAPT 3168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.